In this open discussion webinar, DNA Genotek and Illumina discuss what’s trending in whole genome sequencing (WGS).
To fully benefit from the vast quantities of data from TCGA, tools for easy data visualisation and analysis must be developed for use of the non-computational scientist. Our panel of experts discuss TCGA data and the tools needed to make sense of it.
Comparison of Single Nucleotide Variants in Sequencing Data Produced by Illumina and Oxford Nanopore Technologies.
Come hear from David Grieg, Bioinformatician at Public Health England to learn more about the application of the MinION for the surveillance of Shiga toxin-producing Escherichia coli O157:H7.
Our panel of experts come together to discuss the benefits and drawbacks on the use of saliva DNA in genetic studies and how it’s currently being used to diminish biases in our databases and uncovering the role of epigenetics in psychiatric disorders.
Learn more about Edico Genome’s new DRAGEN Virtual Long-Read Detection (VLRD) Pipeline, that’s the first variant caller dedicated to SDs, and is designed to run with short sequence reads generated at moderate coverage.
A discussion of the technology that is in use today that allows Metabolon to carry out n of 1 studies that enable precision medicine, as well as future technology. Available on-demand.
Looking at applications for the MinION in new molecular approaches for the taxonomy characterization of microbial communities aiming resolution at species and strain level. Available on-demand.
Overcoming challenges of transferring large data to and from the Cloud, while achieving maximum data transfer efficiency, reliability, and security. Available on-demand.
In this webinar, you’ll learn how to increase editing efficiency by directly introducing S. pyogenes Cas9 ribonucleoproteins (RNPs) to cells through electroporation or lipofection.
Learn about novel approaches in addressing the current trends in Big Data, Analytics and Cognitive Computing in tomorrows webinar.
Industry thought leader will discuss his first of its kind work to demonstrate the uptake of blood-based testing for actionable mutations in a non-hospital setting
Explore how Oxford Nanopore Technologies develop their MinION based infectious diseases diagnostics pipelines with examples from ongoing research on pneumonia, sepsis and UTIs
With an introduction to RNA-seq and Q&A moderated by Natalie LaFranzo, PhD, Director of Scientific Projects and Market Development at Cofactor Genomics
How is WGS used as the driving force behind precision medicine to provide diagnosis to rare disease patients? Case studies demonstrating the value of precision medicine and the downstream benefits to the population health will be provided
NGS has triggered a tidal wave of genomic data, whose footprint has rapidly expanded beyond the capacity of our existing storage. In partnership with data optimisation and compression experts Geneformics, we will explore the challenges and opportunities of these giant datasets